Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by JEAN NICOLAS VAUTHEY and EVELYNE M LOYER.
JEAN NICOLAS VAUTHEY
Connection Strength
1.743
EVELYNE M LOYER
  1. RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases. Ann Surg Oncol. 2015 Mar; 22(3):834-842.
    View in: PubMed
    Score: 0.123
  2. Intrabiliary growth of colorectal liver metastasis: spectrum of imaging findings and implications for surgical management. AJR Am J Roentgenol. 2013 Oct; 201(4):W582-9.
    View in: PubMed
    Score: 0.115
  3. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg. 2013 Jun; 257(6):1079-88.
    View in: PubMed
    Score: 0.113
  4. Non-size-based response criteria to preoperative chemotherapy in patients with colorectal liver metastases: the morphologic response criteria. Curr Colorectal Cancer Rep. 2013 Jun 01; 9(2):198-202.
    View in: PubMed
    Score: 0.113
  5. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol. 2012 Dec 20; 30(36):4566-72.
    View in: PubMed
    Score: 0.109
  6. CT findings of response and recurrence, independent of change in tumor size, in colorectal liver metastasis treated with bevacizumab. AJR Am J Roentgenol. 2011 Dec; 197(6):W1060-6.
    View in: PubMed
    Score: 0.102
  7. Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified? Cancer. 2011 Oct 01; 117(19):4484-92.
    View in: PubMed
    Score: 0.097
  8. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011 Mar 10; 29(8):1083-90.
    View in: PubMed
    Score: 0.096
  9. Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases. Am J Surg Pathol. 2010 Sep; 34(9):1287-94.
    View in: PubMed
    Score: 0.093
  10. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA. 2009 Dec 02; 302(21):2338-44.
    View in: PubMed
    Score: 0.089
  11. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005 May; 241(5):715-22, discussion 722-4.
    View in: PubMed
    Score: 0.064
  12. Transdiaphragmatic radiofrequency ablation of liver tumors. J Am Coll Surg. 2004 Nov; 199(5):826-9.
    View in: PubMed
    Score: 0.062
  13. Case 57: eosinophilic cholangiopathy. Radiology. 2003 Apr; 227(1):107-12.
    View in: PubMed
    Score: 0.056
  14. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl. 2002 Mar; 8(3):233-40.
    View in: PubMed
    Score: 0.052
  15. Intrahepatic Recurrence Patterns Predict Survival After Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2019 Jan; 26(1):275-281.
    View in: PubMed
    Score: 0.041
  16. Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab. Gut. 2018 06; 67(6):1095-1102.
    View in: PubMed
    Score: 0.038
  17. Total Transthoracic Approach Facilitates Laparoscopic Hepatic Resection in Patients with Significant Prior Abdominal Surgery. Ann Surg Oncol. 2017 May; 24(5):1376-1377.
    View in: PubMed
    Score: 0.036
  18. Laparoscopic Management of Gallbladder Cancer: A Stepwise Approach. Ann Surg Oncol. 2016 12; 23(Suppl 5):892-893.
    View in: PubMed
    Score: 0.035
  19. Evaluating the Clinical Applicability of the European Staging System for Perihilar Cholangiocarcinoma. J Gastrointest Surg. 2016 Apr; 20(4):741-7.
    View in: PubMed
    Score: 0.034
  20. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015 Nov; 41(9):729-41.
    View in: PubMed
    Score: 0.033
  21. Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancer. Ann Diagn Pathol. 2014 Oct; 18(5):266-70.
    View in: PubMed
    Score: 0.030
  22. Efficacy and safety of portal vein embolization for two-stage hepatectomy in patients with colorectal liver metastasis. J Vasc Interv Radiol. 2014 Apr; 25(4):608-17.
    View in: PubMed
    Score: 0.029
  23. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog. 2013 Nov; 52 Suppl 1:E139-47.
    View in: PubMed
    Score: 0.028
  24. SSAT/AHPBA joint symposium on evaluation and treatment of benign liver lesions. J Gastrointest Surg. 2013 Apr; 17(4):636-44.
    View in: PubMed
    Score: 0.028
  25. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford). 2013 Feb; 15(2):91-103.
    View in: PubMed
    Score: 0.028
  26. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012; 17(10):1225-39.
    View in: PubMed
    Score: 0.027
  27. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol. 2010 May 20; 28(15):2549-55.
    View in: PubMed
    Score: 0.023
  28. Portal thrombosis and steatosis after preoperative chemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases. World J Gastroenterol. 2006 Oct 28; 12(40):6556-8.
    View in: PubMed
    Score: 0.018
  29. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006 May; 141(5):460-6; discussion 466-7.
    View in: PubMed
    Score: 0.017
  30. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004 Apr; 239(4):450-8.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.